Brief CBT for the Treatment of Depression During Inpatient Hospitalization
Launched by NYU LANGONE HEALTH · Jan 4, 2017
Trial Information
Current as of July 22, 2025
Withdrawn
Keywords
ClinConnect Summary
Participants assigned to the CBT condition will receive the usual standard of care during an inpatient psychiatric hospitalization. This includes but is not limited to medication management, group therapy, and individual therapy. If a patient is randomly assigned to the enhanced CBT group, manualized CBT, including a sequence of sessions that builds upon prior sessions and planned exercises, including worksheets and journal entries.The training M.D., who is a treating physician on HCC-10, will also intermittently and randomly observe the CBT sessions to ensure the manual properly is being f...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with depression according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria on initial assessment on the unit.
- • Demonstrates at least moderate degree of depressive symptoms on MADRS, HAM-D, and CGI-S.
- • Provides written informed consent.
- Exclusion Criteria:
- • A mental illness other than depression that is the primary cause of treatment, as determined by the Principal Investigator.
- • A cognitive or neurologic disorder that inhibits ability to engage in CBT.
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Jacqueline Sergie, MD
Principal Investigator
NYU School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials